A S Tamm1, R McCourt2, B Gould2, M Kate2, J C Kosior2, T Jeerakathil2, L C Gioia2, D Dowlatshahi3, M D Hill4, S B Coutts4, A M Demchuk4, B H Buck2, D J Emery1, A Shuaib2, K S Butcher5. 1. Department of Diagnostic Imaging (A.S.T., D.J.E.), University of Alberta, Edmonton, Alberta, Canada. 2. From the Division of Neurology (R.M., B.G., M.K., J.C.K., T.J., L.C.G., B.H.B., A.S., K.S.B.). 3. Division of Neurology (D.D.), University of Ottawa, Ottawa, Ontario, Canada. 4. Department of Clinical Neurosciences (M.D.H., S.B.C., A.M.D.), University of Calgary, Calgary, Alberta, Canada. 5. From the Division of Neurology (R.M., B.G., M.K., J.C.K., T.J., L.C.G., B.H.B., A.S., K.S.B.) ken.butcher@ualberta.ca.
Abstract
BACKGROUND AND PURPOSE: Although blood pressure reduction has been postulated to result in a fall in cerebral perfusion pressure in patients with intracerebral hemorrhage, the latter is rarely measured. We assessed regional cerebral perfusion pressure in patients with intracerebral hemorrhage by using CT perfusion source data. MATERIALS AND METHODS:Patients with acute primary intracerebral hemorrhage were randomized to target systolic blood pressures of <150 mm Hg (n = 37) or <180 mm Hg (n = 36). Regional maps of cerebral blood flow, cerebral perfusion pressure, and cerebrovascular resistance were generated by using CT perfusion source data, obtained 2 hours after randomization. RESULTS:Perihematoma cerebral blood flow (38.7 ± 11.9 mL/100 g/min) was reduced relative to contralateral regions (44.1 ± 11.1 mL/100 g/min, P = .001), but cerebral perfusion pressure was not (14.4 ± 4.6 minutes(-1) versus 14.3 ± 4.8 minutes(-1), P = .93). Perihematoma cerebrovascular resistance (0.34 ± 0.11 g/mL) was higher than that in the contralateral region (0.30 ± 0.10 g/mL, P < .001). Ipsilateral and contralateral cerebral perfusion pressure in the external (15.0 ± 4.6 versus 15.6 ± 5.3 minutes(-1), P = .15) and internal (15.0 ± 4.8 versus 15.0 ± 4.8 minutes(-1), P = .90) borderzone regions were all similar. Borderzone cerebral perfusion pressure was similar to mean global cerebral perfusion pressure (14.7 ± 4.7 minutes(-1), P ≥ .29). Perihematoma cerebral perfusion pressure did not differ between blood pressure treatment groups (13.9 ± 5.5 minutes(-1) versus 14.8 ± 3.4 minutes(-1), P = .38) or vary with mean arterial pressure (r = -0.08, [-0.10, 0.05]). CONCLUSIONS:Perihematoma cerebral perfusion pressure is maintained despite increased cerebrovascular resistance and reduced cerebral blood flow. Aggressive antihypertensive therapy does not affect perihematoma or borderzone cerebral perfusion pressure. Maintenance of cerebral perfusion pressure provides physiologic support for the safety of blood pressure reduction in intracerebral hemorrhage.
RCT Entities:
BACKGROUND AND PURPOSE: Although blood pressure reduction has been postulated to result in a fall in cerebral perfusion pressure in patients with intracerebral hemorrhage, the latter is rarely measured. We assessed regional cerebral perfusion pressure in patients with intracerebral hemorrhage by using CT perfusion source data. MATERIALS AND METHODS:Patients with acute primary intracerebral hemorrhage were randomized to target systolic blood pressures of <150 mm Hg (n = 37) or <180 mm Hg (n = 36). Regional maps of cerebral blood flow, cerebral perfusion pressure, and cerebrovascular resistance were generated by using CT perfusion source data, obtained 2 hours after randomization. RESULTS:Perihematoma cerebral blood flow (38.7 ± 11.9 mL/100 g/min) was reduced relative to contralateral regions (44.1 ± 11.1 mL/100 g/min, P = .001), but cerebral perfusion pressure was not (14.4 ± 4.6 minutes(-1) versus 14.3 ± 4.8 minutes(-1), P = .93). Perihematoma cerebrovascular resistance (0.34 ± 0.11 g/mL) was higher than that in the contralateral region (0.30 ± 0.10 g/mL, P < .001). Ipsilateral and contralateral cerebral perfusion pressure in the external (15.0 ± 4.6 versus 15.6 ± 5.3 minutes(-1), P = .15) and internal (15.0 ± 4.8 versus 15.0 ± 4.8 minutes(-1), P = .90) borderzone regions were all similar. Borderzone cerebral perfusion pressure was similar to mean global cerebral perfusion pressure (14.7 ± 4.7 minutes(-1), P ≥ .29). Perihematoma cerebral perfusion pressure did not differ between blood pressure treatment groups (13.9 ± 5.5 minutes(-1) versus 14.8 ± 3.4 minutes(-1), P = .38) or vary with mean arterial pressure (r = -0.08, [-0.10, 0.05]). CONCLUSIONS:Perihematoma cerebral perfusion pressure is maintained despite increased cerebrovascular resistance and reduced cerebral blood flow. Aggressive antihypertensive therapy does not affect perihematoma or borderzone cerebral perfusion pressure. Maintenance of cerebral perfusion pressure provides physiologic support for the safety of blood pressure reduction in intracerebral hemorrhage.
Authors: Kenneth Butcher; Thomas Jeerakathil; Derek Emery; Dar Dowlatshahi; Michael D Hill; Mukul Sharma; Brian Buck; Max Findlay; Ting Y Lee; Andrew M Demchuk Journal: Int J Stroke Date: 2010-06 Impact factor: 5.266
Authors: A R Zazulia; M N Diringer; T O Videen; R E Adams; K Yundt; V Aiyagari; R L Grubb; W J Powers Journal: J Cereb Blood Flow Metab Date: 2001-07 Impact factor: 6.200
Authors: Laura C Gioia; Mahesh Kate; Victor Choi; Leka Sivakumar; Thomas Jeerakathil; Jayme Kosior; Derek Emery; Ken Butcher Journal: Stroke Date: 2015-04-28 Impact factor: 7.914
Authors: Ken S Butcher; Tracey Baird; Lachlan MacGregor; Patricia Desmond; Brian Tress; Stephen Davis Journal: Stroke Date: 2004-06-03 Impact factor: 7.914
Authors: Miriam Brazzelli; Peter Ag Sandercock; Francesca M Chappell; Maria Grazia Celani; Enrico Righetti; Nicholas Arestis; Joanna M Wardlaw; Jonathan J Deeks Journal: Cochrane Database Syst Rev Date: 2009-10-07
Authors: Peter D Schellinger; Jochen B Fiebach; Katrin Hoffmann; Kristina Becker; Berk Orakcioglu; Rainer Kollmar; Eric Jüttler; Peter Schramm; Stefan Schwab; Klaus Sartor; Werner Hacke Journal: Stroke Date: 2003-06-12 Impact factor: 7.914